James Crowe

James E. Crowe, Jr., MD

James Crowe is a viral immunologist and board-certified pediatric infectious diseases specialist. He is the Director of the Vanderbilt Vaccine Center and a Professor of Pediatrics, Microbiology and Immunology at Vanderbilt University Medical Center.12

Key Positions and Experience

• Director, Vanderbilt Vaccine Center (2006 - Present)
• Professor of Pediatrics, Microbiology and Immunology, Vanderbilt University Medical Center (2006 - Present)
• Founder, IDBiologics (September 2017 - Present), a biotech company developing human monoclonal antibodies for infectious diseases12
• Founder, Corbeau Biotech LLC (August 2009 - August 2017), a biotech company focused on human monoclonal antibody development1

Education and Training

• MD, University of North Carolina at Chapel Hill
• Pediatrics residency, University of North Carolina at Chapel Hill
• Postdoctoral Fellowship in Virology, Immunology and Vaccines, National Institutes of Health (1990-1995)
• Infectious diseases fellowship, Vanderbilt University (1996)2

Awards and Honors

• Elected to the National Academy of Medicine (2014) and National Academy of Inventors (2017)
• Recipient of numerous awards including the Judson Infectious Daland Prize, Oswald Avery Award, E. Mead Johnson Award, Outstanding Investigator Award, and the inaugural 2019 Merck Future Insight Prize2
• His research team was selected as Best Academic Research Team at the 11th Annual Vaccine Industry Excellence Awards2

Dr. Crowe's laboratory has published over 300 papers in high-impact journals and his research focuses on viral immunology and antibody sciences, with the goal of discovering new mechanisms of immunity to develop novel therapeutics and vaccines.2